Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development
2008 · Current Medicinal Chemistry · 356 citations
https://doi.org/10.2174/092986708785132870
Y
Yong Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
220
Papers
3.9K
Citations
32
h-index
69
i10-index
Yong Li is an academic researcher from Beijing Tongren Hospital. The author has contributed to research in topics: interferon and immune responses & Cancer, Hypoxia, and Metabolism & Circular RNAs in diseases. The author has an h-index of 32, co-authored 187 publications.
ORCID: 0000-0001-8265-577XPapers by this author
worksHydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages
2018 · Journal of Experimental & Clinical Cancer Research · 137 citations
https://doi.org/10.1186/s13046-018-0938-5
LINC01939 inhibits the metastasis of gastric cancer by acting as a molecular sponge of miR-17-5p to regulate EGR2 expression
2019 · Cell Death and Disease · 57 citations
https://doi.org/10.1038/s41419-019-1344-4
Cadmium-induced immune abnormality is a key pathogenic event in human and rat models of preeclampsia
2016 · Environmental Pollution · 52 citations
https://doi.org/10.1016/j.envpol.2016.07.073
Ureadepsipeptides as ClpP Activators
2019 · ACS Infectious Diseases · 41 citations
https://doi.org/10.1021/acsinfecdis.9b00245
Enhanced mitochondrial pyruvate transport elicits a robust ROS production to sensitize the antitumor efficacy of interferon-γ in colon cancer
2018 · Redox Biology · 21 citations
https://doi.org/10.1016/j.redox.2018.10.024
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat